SuperSeed Capital Ld - Q4 2025 Results
Announcement provided by
SuperSeed Capital Limited · WWW13/02/2026 07:00
SUPERSEED CAPITAL LIMITED
(the "Company")
UNAUDITED FOURTH QUARTER 2025 RESULTS
SuperSeed Capital Limited, a company established as a venture capital fund of funds for early-stage AI/SaaS companies, announces unaudited results for Q4 2025 and the year ending 31 December 2025. The Company invests in technology-led innovation, primarily through funds managed by SuperSeed Ventures LLP (the "Investment Manager"). The Company's principal investment to date is in SuperSeed II LP (the "Fund").
Financial Highlights for Q4 2025:
· NAV per share has increased by 12p during the quarter, now at
· A total of
Fund Portfolio and Investment Highlights:
· Fund portfolio revenue grew at nearly 100% annualised in Q4 2025.
· Two new companies were added to the Fund portfolio in Q4 2025 (Hive Autonomy and SOLVE Chemistry), with a further two investments completing in Q1 2026 (Cursive and All3).
Outlook for 2026:
· The Fund's investment period has now ended.
· Several companies in the Fund's portfolio are progressing towards Series A, with significant activity expected in H1 2026.
Mads Jensen, Managing Partner of the Investment Manager, commented:
"The Fund portfolio's performance continues to track top-performing VC fund benchmarks globally. Q4 2025 was another strong quarter for the Fund's portfolio, with several companies hitting new valuation milestones and progressing towards major funding rounds. This is expected to drive substantial TVPI expansion in the quarters to come as valuations reflect continued portfolio progress."
For more information, please contact:
|
SuperSeed Capital Limited |
+44(0) 203 405 3060 |
|
Mads Jensen, Investment Manager |
|
|
|
|
|
VSA Capital - AQSE Corporate Adviser and Broker |
+44(0) 203 005 5000 |
|
Corporate Finance: Andrew Raca / Dylan Sadie |
|
About SuperSeed Capital Limited
SuperSeed exists to back
Forward-looking statements
This announcement contains statements that are or may be forward-looking statements. All statements other than statements of historical facts included in this announcement may be forward-looking statements, including statements that relate to the Company's future prospects, developments and strategies. The Company does not accept any responsibility for the accuracy or completeness of any information reported by the press or other media, nor the fairness or appropriateness of any forecasts, views or opinions expressed by the press or other media regarding the Group. The Company makes no representation as to the appropriateness, accuracy, completeness or reliability of any such information or publication.
Forward-looking statements are identified by their use of terms and phrases such as "believe", "targets", "expects", "aim", "anticipate", "projects", "would", "could", "envisage", "estimate", "intend", "may", "plan", "will" or the negative of those, variations or comparable expressions, including references to assumptions. The forward-looking statements in this announcement are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements. Factors that may cause actual results to differ materially from those expressed or implied by such forward looking statements include, but are not limited to, those described in the Risk Management Framework section of the Company's most recent Annual Report. These forward-looking statements are based on numerous assumptions regarding the present and future business strategies of the Group and the environment in which it is and will operate in the future. All subsequent oral or written forward-looking statements attributed to the Company or any persons acting on its behalf are expressly qualified in their entirety by the cautionary statement above. Each forward-looking statement speaks only as at the date of this announcement. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither the Company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
Investment Manager's Review
The Capability Constraint is Over
The technical community has been using Claude Code for a year. It's an agent harness that enables Claude to execute your instructions: not just answering questions, but taking actions on your computer, connecting to data sources, accomplishing objectives. Originally built for writing code, it now works for marketing, email processing, research, and everything else.
Three things happened in January that changed the game:
First, Anthropic released CoWork. This puts Claude Code-like capabilities in the hands of everyone, not just developers. There's been a sudden realisation of just how powerful the agentic way of working is, and now anyone can access it.
Second, the OpenClaw project takes the approach further. Claude Code is still "give me a prompt, go do actions, come back with results." OpenClaw is "here are my objectives for the world, go figure out how to achieve them, even if it takes hours, days, or weeks." You could ask it to produce a podcast: research guests, contact them, create background research, book them in your calendar, reply to their emails, reach out on WhatsApp. Anything you can accomplish through a computer; the agent can try to do. That doesn't mean it will succeed. And many people have trepidation about giving an agent full access to their email, WhatsApp, passwords, everything. But this is the agentic future, and we've just seen a powerful glimpse of it.
Third,
The capability constraint is over. The models are here. The harnesses work. And yet 95% of enterprise AI projects still fail to reach production.
The Real Bottleneck
The failure isn't technical. MIT's 2025 research found the top obstacles are data quality (43%), lack of technical maturity (43%), and skills shortage (35%). S&P Global reports 42% of companies now abandon AI initiatives before production, up from 17% the previous year.
Enterprises have access to powerful models but lack the infrastructure to deploy them. The constraint has shifted from "can we build AI that does this?" to "can we tell if AI did it correctly?".
Software development transformed first, but not because we have systems to check AI output today. It's because the models were trained on those systems. During training, models learned from test suites via reinforcement learning. They got fast feedback on what works and what doesn't. Software has right and wrong answers, unlike so many other fields. The models were beaten into perfection by having first-class, fast feedback during training.
Other sectors lack this training infrastructure. Institutional knowledge lives in people's heads and dies when they leave. Decision logic sits in spreadsheets no one maintains. There's no equivalent of a test suite to train models against, because those verification systems were never built.
Where Value Concentrates
We've written before about the broken economics of AI infrastructure. A
As these economics resolve (inference costs collapsing, open-source matching proprietary at one-tenth the price), value will migrate up the stack. The PC era shifted value from hardware to software. The internet era shifted value from infrastructure to applications. The AI era will shift value from model providers to those who make AI deployable.
The winning companies won't build bigger models. They'll build applications that unlock sector-specific value, with the decision scaffolding and verification that makes AI outputs trustworthy.
This is where the Fund's portfolio sits.
Q4 2025 Fund Portfolio Performance
While the industry debates whether the AI bubble will burst, the Fund's portfolio companies are building applications that transform specific industries. They encode domain expertise, verification systems, and decision infrastructure into software that makes AI actually work.
Fund Metrics
Q4 was the strongest quarter to date, capping 2025 as a strong year:
· Net IRR: 21.1%
· TVPI: 1.25x
· DPI: 0.13x
· Portfolio CARR:
Fund portfolio revenue grew at nearly 100% annualised in Q4.
Over four years, the Fund has delivered 21.1% net IRR compared to 10.6% annualised from holding the S&P 500 (49.4% total return for the S&P 500 over the period). As the Fund's portfolio matures and companies progress through subsequent funding rounds, we expect continued outperformance.
Investment Period Complete
After four years, the Fund's investment period is complete. The Fund has built a portfolio of 27 companies, each applying AI to transform specific sectors.
The timing matters. The Fund began deploying in January 2022, nearly a year before the release of ChatGPT. It invested through the generative AI revolution, watching capabilities explode while deployment remained stubbornly difficult. Now, as the Fund closes its investment period, the industry is finally grappling with the gap between what AI can do and what organisations can verify.
New Investments
Q4 saw two new investments for the Fund, with two more closing in early Q1 2026:
Hive Autonomy is a universal platform for remote and autonomous operation of any industrial vehicle. One operator can control multiple machines simultaneously from a centralised station. Removes workers from dangerous environments, improves productivity. Forklifts, excavators, diggers. These machines move trillions of pounds of materials globally and operate exactly as they did fifty years ago.
SOLVE Chemistry combines automated high-throughput flow chemistry with machine learning. They compress pharmaceutical process development from 9-24 months to weeks, generating 20x more data than traditional methods. Already working with BASF, AstraZeneca, and Hovione.
In early Q1 2026, the Fund completed investments in Cursive (a DeepMind spin-out working on real-time generative AI models, still in stealth) and All3 (construction technology extending our Physical AI thesis into one of the world's largest and least digitised industries).
Portfolio Spotlight: Physical AI
Three of the Fund's investment portfolio companies show where AI creates defensible value in the physical world:
Hive solves implementation where traditional automation fails. Unlike AGVs requiring controlled environments and fixed paths, Hive's AI operates in unpredictable conditions: active warehouses, construction sites, industrial facilities. Every site differs. The expertise isn't in the model. It's making autonomy work where scripted automation breaks down.
OctaiPipe now has ABB as both investor and distribution partner. ABB offers a strong distribution channel for Octaipipe.
All3 applies similar logic to construction. Paper processes, tribal knowledge, and manual coordination waste billions annually. The decision infrastructure that makes AI deployable in construction looks nothing like what works in software. All3 is building it.
Looking Forward
Several of the Fund's investment portfolio companies are progressing toward Series A. We expect significant activity in H1 2026.
The AI revolution accelerates. Models grow more powerful weekly. Open source narrows the gap with proprietary systems. Agentic architectures mature from research to production.
But capability was never the constraint. The companies that win will build applications that make AI actually deployable in specific sectors, with the domain expertise and verification that transforms powerful models into trustworthy software.
That's what we built the Fund's portfolio to do.
Related Party Transactions
Convertible Loan Note Instrument
Further to the announcement made on 26 June 2024, the Company is pleased to announce it has extended the duration of the loan facility, for the issue of convertible loan notes (the "Convertible Loan Notes") to the Investment Manager. As and when issued in the future, the proceeds of the Convertible Loan Notes shall be used to fund the Company's short-term working capital and capital expenditure requirements.
The Convertible Loan Note instrument has been amended such that: 1) the aggregate principal amount of the Notes outstanding at any time has been reduced from
The Convertible Loan Notes shall automatically convert, in part or in full, at any time from the date of issue until the New Redemption Date, into fully paid ordinary shares in the Company at a price of
The Investment Manager is a related party of the Company pursuant to the rules of the Aquis Stock Exchange. The independent directors of the Company, having exercised reasonable care, skill and diligence believe that the extension of the Convertible Loan Notes is fair and reasonable as far as the shareholders of the Company are concerned.
|
SuperSeed Capital Limited |
||||||||
|
Condensed Statement of Comprehensive Income |
||||||||
|
for the year 1 January 2025 to 31 December 2025 |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
1 October 2025 |
|
1 January 2025 |
|
1 January 2025 |
|
1 January 2024 |
|
|
|
to |
|
to |
|
to |
|
to |
|
|
|
31 December 2025 |
|
30 September 2025 |
|
31 December 2025 |
|
31 December 2024 |
|
|
|
£ |
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
||
|
Income |
|
|
|
|
|
|
||
|
Realised gain on investments held at fair value through profit or loss |
|
136,198 |
|
39,285 |
|
175,483 |
|
114,032 |
|
Unrealised gain on investments held at fair value through profit or loss |
|
204,882 |
|
72,152 |
|
277,034 |
|
322,505 |
|
Other income |
|
112 |
|
294 |
|
406 |
|
3,740 |
|
Total income |
|
341,192 |
|
111,731 |
|
452,923 |
|
440,277 |
|
|
|
|
|
|
|
|
|
|
|
Expenses |
|
|
|
|
|
|
||
|
Administration fees |
|
7,842 |
|
23,529 |
|
31,371 |
|
32,406 |
|
Audit fees |
|
7,251 |
|
18,699 |
|
25,950 |
|
25,000 |
|
Directors' fees |
|
5,000 |
|
15,000 |
|
20,000 |
|
20,000 |
|
Insurance |
|
- |
|
1,036 |
|
1,036 |
|
1,036 |
|
Legal & professional fees |
|
9,939 |
|
30,147 |
|
40,086 |
|
47,118 |
|
Loan interest |
|
11,987 |
|
27,968 |
|
39,955 |
|
7,878 |
|
Management fees |
|
2,003 |
|
6,010 |
|
8,013 |
|
7,053 |
|
Regulatory fees |
|
3,563 |
|
12,238 |
|
15,801 |
|
16,813 |
|
Sundry expenses |
|
- |
|
93 |
|
93 |
|
1,102 |
|
Total expenses |
|
47,585 |
|
134,720 |
|
182,305 |
|
158,406 |
|
|
|
|
|
|
|
|
|
|
|
Total gain / (loss) and comprehensive income / (loss) for the period |
|
293,607 |
(22,989) |
|
270,618 |
|
281,871 |
|
|
|
|
|
|
|
|
|
||
|
Basic earnings per share |
|
0.1241 |
|
(0.0097) |
|
0.1144 |
|
0.1192 |
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share |
|
0.1241 |
|
(0.0097) |
|
0.1144 |
|
0.1167 |
|
|
|
|
|
|
|
|
|
|
|
All the above items are derived from continuing operations. |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
SuperSeed Capital Limited |
|||||
|
Condensed Statement of Financial Position |
|||||
|
as at 31 December 2025 |
|||||
|
|
|
|
|
|
|
|
|
31 December 2025 |
|
30 September 2025 |
|
31 December 2024 |
|
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
|
Investments |
3,292,621 |
|
3,487,962 |
|
3,050,658 |
|
Total non-current assets |
3,292,621 |
|
3,487,962 |
|
3,050,658 |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
Trade and other receivables |
7,318 |
|
6,109 |
|
7,417 |
|
Cash and cash equivalents |
36,062 |
|
29,759 |
|
27,870 |
|
Total current assets |
43,380 |
|
35,868 |
|
35,287 |
|
|
|
|
|
|
|
|
Total assets |
3,336,001 |
|
3,523,830 |
|
3,085,945 |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
Trade and other payables |
47,499 |
|
38,121 |
|
43,403 |
|
Loans payable |
50,402 |
|
541,216 |
|
75,060 |
|
Total current liabilities |
97,901 |
|
579,337 |
|
118,463 |
|
|
|
|
|
|
|
|
Total liabilities |
97,901 |
|
579,337 |
|
118,463 |
|
|
|
|
|
|
|
|
Net assets |
3,238,100 |
|
2,944,493 |
|
2,967,482 |
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
Share capital |
2,369,743 |
|
2,369,743 |
|
2,369,743 |
|
Retained earnings |
868,357 |
|
574,750 |
|
597,739 |
|
Total equity |
3,238,100 |
|
2,944,493 |
|
2,967,482 |
|
|
|
|
|
|
|
|
Net asset value per ordinary share |
1.3688 |
|
1.2447 |
|
1.2544 |
|
|
|
|
|
|
|
|
Net asset value per ordinary share inclusive of notional management fee* |
1.3325 |
|
1.2084 |
|
1.2179 |
|
|
|
|
|
|
|
|
*In accordance with Section 13.1.2 of the Alternative Investment Management Agreement between the Company and SuperSeed Ventures LLP (the "Manager") dated 21 January 2022, the Manager is entitled to receive from the Company a management fee of 20% of the aggregate net realised profits on investments, provided that no fee shall be payable in connection with any investment in respect of which the Manager already receives a fee. If all assets were to be realised at the current valuation, the Manager would be due management fees in the amount of |
|||||
|
|
|
|
|
|
|
|
SuperSeed Capital Limited |
||||||
|
Condensed Statement of Changes in Equity |
||||||
|
for the year 1 January 2025 to 31 December 2025 |
||||||
|
|
|
|
|
|
|
|
|
|
|
Share Capital |
|
Retained Earnings |
|
Total |
|
|
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
Balance as at 1 January 2025 |
|
2,369,743 |
|
597,739 |
|
2,967,482 |
|
|
|
|
|
|
|
|
|
Total comprehensive income for the year |
|
- |
|
270,618 |
|
270,618 |
|
|
|
|
|
|
|
|
|
Balance as at 31 December 2025 |
|
2,369,743 |
|
868,357 |
|
3,238,100 |
|
|
|
|
|
|
|
|
|
SuperSeed Capital Limited |
|||||||
|
Condensed Statement of Cash Flows |
|||||||
|
for the year 1 January 2025 to 31 December 2025 |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
1 October 2025 |
|
1 January 2025 |
|
1 January 2024 |
|
|
|
|
to |
|
to |
|
to |
|
|
|
|
31 December 2025 |
|
31 December 2025 |
|
31 December 2024 |
|
|
|
|
£ |
|
£ |
|
£ |
|
|
Cash flows used in operating activities |
|
|
|
|
|
|
|
|
Net cash flow used in operating activities |
|
(27,317) |
|
(137,749) |
|
(136,662) |
|
|
|
|
|
|
|
|
|
|
|
Cash flows from / (used in) investing activities |
|
|
|
|
|
|
|
|
Net cash flow from / (used in) investing activities |
|
536,421 |
|
210,554 |
|
(1,835) |
|
|
|
|
|
|
|
|
|
|
|
Cash flows (used in) / from financing activities |
|
|
|
|
|
|
|
|
Net cash flow (used in) / from financing activities |
|
(502,801) |
|
(64,613) |
|
67,182 |
|
|
|
|
|
|
|
|
|
|
|
Net movement in cash and cash equivalents during the period |
6,303 |
|
8,192 |
|
(71,315) |
||
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at the beginning of the period |
29,759 |
|
27,870 |
|
99,185 |
||
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at the end of the period |
36,062 |
|
36,062 |
|
27,870 |
||
|
|
|
|
|
|
|
|
|
|
SuperSeed Capital Limited |
||||||
|
Investment Analysis |
||||||
|
for the year 1 January 2025 to 31 December 2025 |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
31 December 2025 |
|
31 December 2024 |
|
|
|
|
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
Cost |
|
|
2,135,128 |
|
2,170,199 |
|
|
Cumulative movement in value |
|
|
1,157,493 |
|
880,459 |
|
|
Fair value |
|
|
3,292,621 |
|
3,050,658 |
|
|
|
|
|
|
|
|
|
|
Investment fair value can be further analysed as follows: |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
1 October 2025 |
|
1 January 2025 |
|
1 January 2024 |
|
|
|
to |
|
to |
|
to |
|
|
|
31 December 2025 |
|
31 December 2025 |
|
31 December 2024 |
|
|
|
£ |
|
£ |
|
£ |
|
Cost |
|
|
|
|
|
|
|
Cost at beginning of the period |
2,535,351 |
|
2,170,199 |
|
1,875,058 |
|
|
Cost of investment - settled |
238,511 |
|
770,794 |
|
905,788 |
|
|
Cost of investment - sold |
(638,734) |
|
(805,865) |
|
(610,647) |
|
|
Total cost of investment |
2,135,128 |
|
2,135,128 |
|
2,170,199 |
|
|
|
|
|
|
|
|
|
|
Fair value movement |
|
|
|
|
|
|
|
Fair value adjustment at beginning of the period |
952,611 |
|
880,459 |
|
557,954 |
|
|
Revaluation of underlying investments |
204,882 |
|
277,034 |
|
322,505 |
|
|
|
|
1,157,493 |
|
1,157,493 |
|
880,459 |
|
Fair value of investments |
3,292,621 |
|
3,292,621 |
|
3,050,658 |
|
|
|
|
|
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.